Cresco Labs – “Sort of” Reports Q2 Earnings

Last night, Cresco Labs (CSE: CL), released their unaudited financial results for Q2/19, well sort of…. They released a news release with key select data, and didn’t post the financial statements on Sedar. A trend common with many other MSOs, where they “release” their earnings in a news release, and then post the financial statements and MD&A weeks after.

Source: Sedar

The company did not disclose a cash flow statement, or any of the critical accounting notes, and in terms of the balance sheet the multi-billion dollar corporation posted the following:

We went back through the last 3 quarters to try to give investors a look at how the company is doing through the following lines we could obtain:

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines
 QoQ  Δ%Q2’19Q1’19Q4’18
Revenue41.96% $    29,890.00  $  21,055  $  16,957
Gross Profit19.65% $    12,745.00  $  10,652  $  24,297
Gross Margin n/a43%51%143%
Income Taxes-15197.30% $    (5,586.00) $          37  $    3,555
Net Income-48.27% $    (3,918.00) $  (7,574) $  (2,606)
EBITDA n/a $      6,415.00  $  (4,808) $      (252)
Adjusted EBITDA1667.97% $    14,462.00  $        818  $  14,559

Commentary

At this stage it is very difficult to assess how Cresco is performing for shareholders. There are many moving parts and they will continue to need more cash. The company has completed and continues to work towards various acquisitions that will make it difficult for investors to gauge how accretive each deal looks like. The bright side is that the company is generating positive EBITDA and paying more in income taxes than most cannabis companies would dream of. A sign they are selling real cannabis and are a real operating business.

Beyond that, the company still awaits pending deals in New York, Massachusetts, Michigan and Florida. These deals will certainly alter the cap table, but give Cresco a larger footprint in tremendous growth states. As of the end of last quarter, the company had $61.1M cash on the balance sheet. Given the deals Cresco has on the table, one would assume they will be raising cash to close each deal and further build out. But hey, it’s cannabis, everyone has their next raise around the corner!


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Cresco Labs Closes Acquisition Of Bluma Wellness

Cresco Labs (CSE: CL) has completed its acquisition of Bluma Wellness (CSE: BWEL.u), thus solidifying...

Thursday, April 15, 2021, 07:27:13 AM

Cresco Labs: Canaccord Lowers Price Target To $19

Cresco Labs (CSE: CL) reported its first-quarter financial results this past week. The company announced...

Sunday, May 30, 2021, 01:07:00 PM

Cresco Labs Terminates Acquisition of VidaCann

Cresco Labs (CSE: CL) announced this morning that it is terminating its previously announced acquisition...

Tuesday, November 26, 2019, 08:34:42 AM

Cresco Labs: Canaccord, Eight Capital Raise Price Targets

Cresco Labs (CSE: CL) reported its second-quarter 2020 financials yesterday, posting revenue growth of 42%...

Friday, August 21, 2020, 04:03:00 PM

Cresco Labs: Cantor Lowers Price Target To $12.65

On September 3, Cresco Labs (CSE: CL) announced that they closed their acquisition of Cultivate,...

Thursday, September 16, 2021, 03:37:00 PM